secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001140361-24-036026
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotech to announce Q2 2024 results on August 13, 2024
----------------------------------------------------------

- Company will report Q2 2024 financial results and provide business update before market open on August 13, 2024.
- Press release will be available on the Investor Relations section of PDS Biotech's website.
- No financial figures, guidance changes, or material updates included in this pre-announcement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036124036026/0001140361-24-036026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036124036026/ef20033709_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-036026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer